CORRECTION OF METABOLIC DISORDERS IN OBESITY IN ADOLESCENTS
DOI:
https://doi.org/10.54890/.v4i4.1066Abstract
The article presents data on the use of the drug ursodeoxycholic acid in hepatomegaly and fatty hepatosis in 50 obese adolescents. The purpose of the work was to study metabolic disorders in obesity in adolescents and the effectiveness of the use of ursodeoxycholic acid in correcting these changes. The subjects of the study were 50 obese adolescents aged 10 to 18 years. The teenagers were divided into 2 groups of 25 people using random sampling. Children of the main group, in addition to non-drug treatment, received the drug ursodesocholic acid in an age-appropriate dosage. The analysis was carried out according to objective examination, instrumental and laboratory studies. Based on the analysis data, it was found that the condition of the liver in adolescents with obesity is characterized by changes in the form of liver enlargement, the appearance of fatty hepatosis and changes in the lipid profile. After completing the study, it was concluded that there was a significant positive clinical and functional dynamics of the disease in the first group while taking ursodeoxycholic acid. In the second group, there was a lack of dynamics and even some deterioration in clinical and functional indicators.
The use of ursodeoxycholic acid drugs in addition to non-drug treatment leads to a significant improvement in clinical symptoms and lipid metabolism in adolescents.
Keywords:
adolescents, obesity, hepatomegaly, fatty hepatosis, ursodeoxycholic acid.References
1. Ахмедова Р.М. Ожирение у детей и подростков: распространенность, клинико-метаболические особенности, возможности терапии и профилактики [автореф. дис.]. Пермь; 2015. 23 с. [Akhmedova R.M. Obesity in children and adolescents: prevalence, clinical and metabolic features, possibilities of therapy and prevention [abstract dis.]. Perm; 2015. 23 p. (in Russ.).]
2. Бокова Т.А. Факторы риска формирования метаболического синдрома у детей с ожирением. Российский вестник перинатологии и педиатрии. 2018;3:64–69. [Bokova T.A. Risk factors for the formation of metabolic syndrome in obese children. Russian Bulletin of Perinatology and Pediatrics. 2018;3:64–69. (in Russ.).] https://doi.org/10.21508/1027-4065-2018-63-3-64-69
3. Министерство здравоохранения, ЮНИСЕФ, ФАО, ВПП, ВОЗ, USDA, Мерсико и USAID. Национальное интегрированное исследование микронутриентного статуса и антропометрических показателей среди детей, девочек-подростков и женщин репродуктивного возраста в Кыргызской Республике. Краткий статистический обзор. Бишкек; 2022. Режим доступа: https://www.unicef.org/kyrgyzstan/reports/national-integrated-micronutrient-and-anthropometric-survey-kyrgyz-republic-nimas. [Ministry of Health of the Kyrgyz Republic, UNICEF, FAO, WFP, WHO, USAID, USAID Advancing Nutrition, Mercy Corps. National integrated study of micronutrient status and anthropometric indicators among children, adolescent girls and women of reproductive age in the Kyrgyz Republic. Brief statistical review. Bishkek; 2022. (in Russ.).]
4. Чеснокова Л.В., Петров И.М., Трошина И.А., Медведева И.В. Инсулинорезистентность, атерогенные нарушения и фиброз печени у больных с метаболическим синдромом. Ожирение и метаболизм. 2014;2:17–23. [Chesnokova L.V., Petrov I.M., Troshina I.A., Medvedeva I.V. Insulin resistance, atherogenic disorders and liver fibrosis in patients with metabolic syndrome. Obesity and metabolism. 2014;2:17–23. (in Russ.).]
5. Григорьев К.И., Харитонова Л.А., Юдина Е.А., Потапова Е.А. Метаболический синдром у детей и подростков. Вопросы детской диетологии. 2017;15(6):53–58. [Grigoriev K.I., Kharitonova L.A., Yudina E.A., Potapova E.A. Metabolic syndrome in children and adolescents. Questions of children's nutrition. 2017;15(6):53–58. (in Russ.).]
6. Фурман Е.Г., Корюкина И.П., Зарницына Н.Ю., Пономарёва М.С., Чистоусова Г.В., Ахмедова Р.М. Неалкогольная жировая болезнь печени при эндокринных заболеваниях у детей и подростков. Экспериментальная и клиническая гастроэнтерология. 2018;156(8):35-40. [Furman E.G., Koryukina I.P., Zarnitsyna N.Yu., Ponomareva M.S., Chistousova G.V., Akhmedova R.M. Non-alcoholic fatty liver disease in endocrine diseases in children and adolescents. Experimental and clinical gastroenterology. 2018;156(8): 35-40. (in Russ.).] https://doi.org/10.31146/1682-8658-ecg-156-8-35-40
7. Корой П.В., Сляднев С.А., Кравченко Ю.А., Ягода А.В. Влияние метаболического синдрома на течение неалкогольной жировой болезни печени. Терапия. 2019;5(3):37-42. [Koroy P.V., Slyadnev S.A., Kravchen-ko Yu.A., Yagoda A.V. Influence of metabolic syndrome on course of non-alcoholic fatty liver disease. Terapiya. Therapy. 2019;5(3):37-42. (in Russ.).] https://doi.org/10.18565/therapy.2019.3.37-42
8. Тимакова А.Ю., Скирденко Ю.П., Ливзан М.А., Кролевец Т.С., Николаев Н.А., Нелидова А.В. Кардиоваскулярная коморбидность при неалкогольной жировой болезни печени. Экспериментальная и клиническая гастроэнтерология. 2020;182(10):88-95. [Timakova A.Yu., Skirdenko Yu.P., Livzan M.A., Krolevets T.S., Nikolaev N.A., Nelidova A.V. Cardiovascular comorbidity in non-alcoholic fatty liver disease. Eksperimental'naya i klinicheskaya gastroenterologiya /Experimental
and Clinical Gastroenterology. 2020;182(10):88-95. in Russ.).] https://doi.org/10.31146/1682-8658-ecg-182-10-88-95
9. Власов Н.Н., Корниенко Е.А. Неалкогольная жировая болезнь печени и метаболический синдром в детском возрасте. Экспериментальная и клиническая гастроэнтерология. 2020;183(11):51-61. [Vlasov N.N., Kornienko E.A. Non-alcoholic fatty liver disease and metabolic syndrome in childhood. Eksperimental'naya i klinicheskaya gastroenterologiya / Experimental and Clinical Gastroenterology. 2020;183(11):51-61. (In Russ.).] https://doi.org/10.31146/1682-8658-ecg-183-11-51-61
Downloads
Published
How to Cite
Issue
Section
